These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25352244)

  • 1. Differences in quantitative assessment of myocardial scar and gray zone by LGE-CMR imaging using established gray zone protocols.
    Mesubi O; Ego-Osuala K; Jeudy J; Purtilo J; Synowski S; Abutaleb A; Niekoop M; Abdulghani M; Asoglu R; See V; Saliaris A; Shorofsky S; Dickfeld T
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):359-68. PubMed ID: 25352244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of phase correction of late gadolinium enhancement images on scar signal quantification in patients with ischemic and non-ischemic cardiomyopathy.
    Stirrat J; Joncas SX; Salerno M; Drangova M; White J
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):66. PubMed ID: 26248535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of semi-automated scar quantification techniques using high-resolution, 3-dimensional late-gadolinium-enhancement magnetic resonance imaging.
    Rajchl M; Stirrat J; Goubran M; Yu J; Scholl D; Peters TM; White JA
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):349-57. PubMed ID: 25307896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
    Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy.
    Mikami Y; Kolman L; Joncas SX; Stirrat J; Scholl D; Rajchl M; Lydell CP; Weeks SG; Howarth AG; White JA
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):85. PubMed ID: 25315701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women's Interagency HIV Study.
    Kato Y; Kizer JR; Ostovaneh MR; Lazar J; Peng Q; van der Geest RJ; Lima JAC; Ambale-Venkatesh B
    BMC Med Imaging; 2021 Jul; 21(1):116. PubMed ID: 34315432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMR-based identification of critical isthmus sites of ischemic and nonischemic ventricular tachycardia.
    Piers SR; Tao Q; de Riva Silva M; Siebelink HM; Schalij MJ; van der Geest RJ; Zeppenfeld K
    JACC Cardiovasc Imaging; 2014 Aug; 7(8):774-84. PubMed ID: 25051947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of peri-infarct scar on late gadolinium enhancement cardiac magnetic resonance imaging and outcome in patients with ischemic cardiomyopathy.
    Tülümen E; Rudic B; Ringlage H; Hohneck A; Röger S; Liebe V; Kuschyk J; Overhoff D; Budjan J; Akin I; Borggrefe M; Papavassiliu T
    Heart Rhythm; 2021 Jun; 18(6):954-961. PubMed ID: 33515714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of late gadolinium enhancement image quality using a deep learning-based reconstruction algorithm and its influence on myocardial scar quantification.
    van der Velde N; Hassing HC; Bakker BJ; Wielopolski PA; Lebel RM; Janich MA; Kardys I; Budde RPJ; Hirsch A
    Eur Radiol; 2021 Jun; 31(6):3846-3855. PubMed ID: 33219845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of dark-blood late gadolinium enhancement cardiovascular magnetic resonance without additional magnetization preparation.
    Holtackers RJ; Van De Heyning CM; Nazir MS; Rashid I; Ntalas I; Rahman H; Botnar RM; Chiribiri A
    J Cardiovasc Magn Reson; 2019 Jul; 21(1):44. PubMed ID: 31352900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions.
    Spiewak M; Małek LA; Chojnowska L; Miśko J; Petryka J; Kłopotowski M; Milosz B; Polańska M; Ruzyłło W
    Int J Cardiovasc Imaging; 2010 Aug; 26(6):693-9. PubMed ID: 20349138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
    Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models.
    de Haan S; Meijers TA; Knaapen P; Beek AM; van Rossum AC; Allaart CP
    Heart; 2011 Dec; 97(23):1951-6. PubMed ID: 21917670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance.
    Flett AS; Hasleton J; Cook C; Hausenloy D; Quarta G; Ariti C; Muthurangu V; Moon JC
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):150-6. PubMed ID: 21329899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing a novel automatic 3D method for LGE-CMR quantification of scar size with established methods.
    Woie L; Måløy F; Eftestøl T; Engan K; Edvardsen T; Kvaløy JT; Ørn S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):339-47. PubMed ID: 24249515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.
    Zeidan-Shwiri T; Yang Y; Lashevsky I; Kadmon E; Kagal D; Dick A; Laish Farkash A; Paul G; Gao D; Shurrab M; Newman D; Wright G; Crystal E
    Heart Rhythm; 2015 Apr; 12(4):802-8. PubMed ID: 25583153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis.
    Gräni C; Eichhorn C; Bière L; Kaneko K; Murthy VL; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    J Cardiovasc Magn Reson; 2019 Feb; 21(1):14. PubMed ID: 30813942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.